Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity 论文
2021EBioMedicine引用 397顶会
Computational Drug Discovery MethodsPharmacological Receptor Mechanisms and EffectsCOVID-19 Clinical Research Studies
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity · 相关事件
暂无数据